CoChat

Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide’s effect on glycemia

Open access
Ionut, Viorica, Castro, Ana Valeria B., Woolcott, Orison O., Stefanovski, Darko, Iyer, Malini S., Broussard, Josiane L., Burch, Miguel, Elazary, Ram, Kolka, Cathryn M., Mkrtchyan, Hasmik, Bediako, Isaac Asare, Bergman, Richard N. · 2014 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 13

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The hepatoportal area is an important glucohomeostatic metabolic sensor, sensing hypoglycemia, hyperglycemia, and hormones such as glucagon-like peptide-1 (GLP-1). We have reported previously that activation of hepatoportal sensors by intraportal infusion of glucose and GLP-1 or by subcutaneous administration of GLP-1 receptor activator exenatide and of intraportal glucose improved glycemia independent of corresponding changes in pancreatic hormones. It is not clear whether this effect is mediated via the portal vein (PV) or by direct action on the liver itself. To test whether receptors in the PV mediate exenatide's beneficial effect on glucose tolerance, we performed 1) paired oral glucose tolerance tests (OGTT) with and without exenatide and 2) intravenous glucose tolerance tests before and after PV denervation in canines. Denervation of the portal vein affected oral glucose tolerance; post-denervation (POST-DEN) OGTT glucose and insulin AUC were 50% higher than before denervation ( P = 0.01). However, portal denervation did not impair exenatide's effect to improve oral glucose tolerance (exenatide effect: 48 ± 12 mmol·l−1·min before vs. 64 ± 26 mmol·l−1·min after, P = 0.67). There were no changes in insulin sensitivity or secretion during IVGTTs. Portal vein sensing might play a role in controlling oral glucose tolerance during physiological conditions but not in pharmacological activation of GLP-1 receptors by exenatide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00244.2014

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 13

Metadata

Authors
Ionut, V., Castro, A. V. B., Woolcott, O. O., Stefanovski, D., Iyer, M. S., Broussard, J. L., Burch, M., Elazary, R., Kolka, C. M., Mkrtchyan, H., Bediako, I. A., & Bergman, R. N.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2014-10-15
Volume
307
Issue
8
Pages
E644-E652
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W1979117741
Cited by
13
References
6
FWCI
1.44
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide’s effect on glycemia. https://app.cochat.ai/papers/10.1152/ajpendo.00244.2014
The paper
Ionut, V., Castro, A. V. B., Woolcott, O. O., Stefanovski, D., Iyer, M. S., Broussard, J. L., Burch, M., Elazary, R., Kolka, C. M., Mkrtchyan, H., Bediako, I. A., & Bergman, R. N. (2014). Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide’s effect on glycemia. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00244.2014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.